Literature DB >> 21878242

Defective function at the epithelial junction: a novel therapeutic frontier in asthma?

Darryl A Knight, Stephen M Stick, Tillie-Louise Hackett.   

Abstract

Mesh：

Year:  2011        PMID： 21878242     DOI： 10.1016/j.jaci.2011.07.031

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  5 in total

Review 1.  Airway epithelial barrier dysfunction in the pathogenesis and prognosis of respiratory tract diseases in childhood and adulthood.

Authors:  Hasan Yuksel; Ahmet Turkeli
Journal:  Tissue Barriers       Date:  2017-09-08

2.  Restricted access or access all areas? a new cadherin-like protein upregulated in the inflamed esophagus.

Authors:  D A Knight; P M Hansbro
Journal:  Mucosal Immunol       Date:  2018-01       Impact factor: 7.313

Review 3.  Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation.

Authors:  Steve N Georas; Fariba Rezaee
Journal:  J Allergy Clin Immunol       Date:  2014-07-29       Impact factor: 10.793

4.  Anti-VEGF treatment suppresses remodeling factors and restores epithelial barrier function through the E-cadherin/β-catenin signaling axis in experimental asthma models.

Authors:  Ahmet Türkeli; Özge Yilmaz; Meral Karaman; Esra Toprak Kanik; Fatih Firinci; Sevinç İnan; Hasan Yüksel
Journal:  Exp Ther Med       Date:  2021-04-29       Impact factor: 2.447

5.  Protocadherin-1 Localization and Cell-Adhesion Function in Airway Epithelial Cells in Asthma.

Authors:  Grissel Faura Tellez; Brigitte W M Willemse; Uilke Brouwer; Susan Nijboer-Brinksma; Karl Vandepoele; Jacobien A Noordhoek; Irene Heijink; Maaike de Vries; Natalie P Smithers; Dirkje S Postma; Wim Timens; Laura Wiffen; Frans van Roy; John W Holloway; Peter M Lackie; Martijn C Nawijn; Gerard H Koppelman
Journal:  PLoS One       Date:  2016-10-04       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.